pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
910
stories
26d
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
26d
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
26d
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
biospace
26d
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
fiercebiotech
26d
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
26d
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
26d
FDA has recommitted to adcomms—but to what end?
biospace
26d
Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases
fiercebiotech
26d
FDA finalizes three guidances to broaden cancer clinical trial eligibility
raps
29d
Sanofi halts development of troubled immune drug in eczema
biopharma dive
29d
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
biospace
29d
Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
biopharma dive
29d
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
29d
Summit has less than a year of cash runway left as PD-1/VEGF verdict nears
biospace
29d
Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
fda medwatch
29d
FDA panel endorses broader use of certain peptides
biopharma dive
Jul 23, 26
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 23, 26
Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drug
endpoints
Jul 23, 26
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
fiercebiotech
Jul 23, 26
BeOne commits $300M to US manufacturing expansion, creating 120 new jobs
biospace
Jul 23, 26
Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
biospace
Jul 23, 26
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
biospace
Jul 23, 26
Scancell to go public after winning reverse merger bid for troubled Neuphoria
fiercebiotech
Jul 23, 26
Make or break: Commercial hires critical for success
biospace
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jul 22, 26
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
Jul 22, 26
GSK lung cancer drug gets speedy approval following $10.6B deal
biopharma dive
Jul 22, 26
Former FDA cancer chief Pazdur says the agency should restructure
endpoints
Jul 22, 26
FDA approves Nuvalent's cancer drug, a week after GSK closed $10.6B buyout
endpoints
← prev
page 10 of 31
next →
